Abstract: The present application relates to a novel Aspergillus oryzae CJI1100 strain and a mycelium produced therefrom. Using the novel Aspergillus oryzae CJI1100 strain of the present application, a mycelium including all the kinds of essential amino acids can be mass-produced. The mycelium of the present application has, as a complete protein, the advantage of being used in various foods, including meat substitutes.

Abstract: A method of recommending, by a recommendation apparatus, an asset and content to a user, and including receiving learning data from a platform for using the content and an authorizing tool for producing the content; constructing a learning model based on the training data; generating 1/a first model for analyzing characteristics of the user, 2) a second model for recommending the content, and 3) a third model for recommending the element using the learning model; transferring recommended content information to the platform using the first model and the second model; and transferring recommended element information to the authorizing tool.

Abstract: The disclosed technology generally relates to forming a titanium nitride-based thin films, and more particularly to a conformal and smooth titanium nitride-based thin films and methods of forming the same. In one aspect, a method of forming a thin film comprising one or both of TiSiN or TiAlN comprises exposing a semiconductor substrate to one or more vapor deposition cycles at a pressure in a reaction chamber greater than 1 torr, wherein a plurality of the vapor deposition cycles comprises an exposure to a titanium (Ti) precursor, an exposure to a nitrogen (N) precursor and an exposure to one or both of a silicon (Si) precursor or an aluminum (Al) precursor.

Abstract: The present invention relates to a health functional food, a food and a cosmetic composition for anti-oxidation, wrinkle improvement, elasticity improvement and skin moisturizing comprising a complex of an Indian gooseberry (Phyllanthus emblica) extract and a barley sprout (Hordeum vulgare) as an active ingredient. The complex provided from the present invention has excellent DPPH scavenging activity, elastase inhibitory activity, MMP-1 inhibitory activity and hyaluronic acid content increasing effect, so it can be used as a health functional food, a food and a cosmetic composition for anti-oxidation, wrinkle improvement, elasticity improvement and skin moisturizing.

Abstract: Disclosed therein are a method, an apparatus, and a storage medium for image encoding/decoding. Templating matching is used for prediction for a target block. Prediction information to be applied to encoding of the target block is determined, and prediction for the target block that uses the determined prediction information is performed. The prediction information includes a list and multiple candidates in the list. When the multiple candidates in the list are configured, template matching between blocks may be used. A candidate selected from among multiple candidates configured using template matching is used for prediction for the target block.

Abstract: The present disclosure relates to a method for preparing cells for cancer treatment and a kit for cancer treatment comprising cells prepared by the method. The preparation method of the present disclosure can provide F cells, which, in spite of having no difference in the proliferative capacity compared with mesenchymal stem cells expressing cytosine deaminase that are harvested and used immediately after the culture, exhibit a very excellent tumor suppressive effect through the treatment together with 5-FC and induce a remarkable synergistic effect exceeding an effect from combinative treatment with an existing anticancer drug in cases of a combinative treatment with another anticancer drug. Therefore, the present disclosure can be utilized for a kit for cancer treatment comprising such F cells, and thus can be favorably used to maximize the effect of existing cancer treatments.

Abstract: A new use of M-CSF or G-CSF for diagnosis or treatment of pulmonary fibrosis is disclosed. A marker for diagnosing the level of development or progression of pulmonary fibrosis contains M-CSF and/or G-CSF; and a composition for preventing or treating pulmonary fibrosis, contains an M-CSF inhibitor and a G-CSF inhibitor as active ingredients. The present inventors have ascertained that M-CSF and/or G-CSF is a marker for development or progression of pulmonary fibrosis, and have confirmed that a composition, which contains M-CSF and G-CSF and which binds to M-CSF and G-CSF so that the inherent mechanism thereof can be prevented, has an effect of significantly inhibiting myofibroblast hyperplasia or pulmonary fibrosis of the pulmonary cells, and thus the marker and the composition of the present disclosure are expected to be effectively usable for diagnosis, prevention or treatment of pulmonary fibrosis.

Abstract: A corner structure of a liquefied gas storage tank is provided, wherein the corner structure is installed at a corner of the storage tank for storing liquefied gas to support sealing walls. The corner structure includes: a stationary member secured to an inner surface of a hull structure wall; a movable member disposed on the stationary member such that the sealing walls are joined thereto; and an insulating member interposed between the sealing walls and the hull structure wall. The stationary member includes a stationary member body bent at a curved portion thereof in an opposite direction to the movable member, and the movable member includes a movable member body bent at a bent portion thereof in an opposite direction to the stationary member. The stationary member and the movable member are coupled to each other by a fastening member that penetrates the curved portion and the bent portion.

Abstract: A gene insertion location analysis system for a stem cell therapeutic agent having a specific gene inserted therein comprises: a basic information management unit for managing information essential for operating a gene insertion location analysis system for a stem cell therapeutic agent having a specific gene inserted therein; a gene insertion location analysis unit for managing information for the gene insertion location analysis system; and a DB management unit for managing a DB generated or referred by the basic information management unit and gene insertion location analysis unit.

Abstract: An autonomous driving control apparatus for controlling an autonomous vehicle to travel by avoiding a static object located on a driving path and a method thereof. The autonomous driving control apparatus may include a memory storing map data including road information, a sensor configured to detect an object, and a processor coupled to the memory and the sensor. The processor may be configured to determine, using the sensor, a static object located in an exit section of an intersection associated with a vehicle, determines a drivable area, based on a location of the static object and the road information included in the map data, determine, based on the drivable area, a driving path for the vehicle to avoid a collision with the static object, and control a movement of the vehicle along the driving path.

Abstract: A glaucoma progression prediction system and method for predicting the progression of glaucoma are described. The glaucoma progression prediction system comprises: an examination module provided to derive examination images captured of deep vessels of the eye; a measurement module for measuring the deep vessel density in the examination images; an analysis module for deriving the amount of change in the deep vessel density measured in the plurality of the examination images derived at certain intervals of time; and a determination module for determining the progression of glaucoma according to the amount of change in the deep vessel density.

Abstract: According to an embodiment, a braking apparatus for a vehicle is advantageous in that this secures the reliability and backup brake performance of a pedal stroke sensor, so that it is possible to prevent a problem in which the brake performance of the vehicle has an error while the vehicle is driving.

Abstract: A display substrate according to the embodiment includes: a base material having a long direction and a short direction, and including one surface and the other surface, and a first region and a second region; and a hole passing through the one surface and the other surface of the base material, wherein the first region is defined as a folding region in which the one surface is folded to face, the second region is defined as an unfolding region, the hole includes a first hole formed in the first region, and the first hole includes at least three first holes having different sizes in the long direction of the base material.

Abstract: A Chrysanthemum zawadskii (abbrev. to “Chrysanthemum”) extract with adjusted contents of each of indicator components of Chrysanthemum zawadskii (abbrev. to “Chrysanthemum”) is disclosed. The indicator components include linarin, chlorogenic acid and isochlorogenic acid. Also disclosed is a method for setting a standard for contents of the indicator components by identifying causes of the difference in properties of the Chrysanthemum extract or raw material and standardizing a preparation process from the analyzed causes of the difference in properties, to obtain a Chrysanthemum extract standardized by setting a content range of each indicator component in the Chrysanthemum raw material. Uses of the extract or a composition containing the extract are disclosed.

Abstract: Provided is an electronic device that includes a housing at least partially including a metal portion, a glass plate mounted on one surface of the housing, and a buffer disposed at least on the metal portion on one face of the housing and disposed adjacent to an edge of the glass plate.

Abstract: The present invention relates to: a recombinant protein in which an interferon-beta mutein, in which an amino acid residue is substituted, and an antibody binding to a specific antigen are fused together; and a pharmaceutical composition for treating cancer, the composition comprising, as active ingredients, a polynucleotide, an expression vector and a recombinant microorganism, and the recombinant protein. In the recombinant protein, the physical properties of interferon-beta are improved through site-specific mutation, and thus the recombinant protein may have improved biological activity and purification efficiency, and the productivity thereof can be increased.

Abstract: The present specification provides a method for a terminal performing visual coding, the method including: generating a page for the visual coding and placing an asset on the page; setting a target asset that is a target of the visual coding on the basis of the placed asset; setting a user motion associated with an interaction with a user; setting a result associated with the target asset on the basis of the user motion; and displaying the result of the target asset on the basis of the user motion inputted, in which the result includes: a “function” for controlling size, position and state value of the target asset; a “computation” for computing variables associated with the target asset; and a “function page” representing a movement of the page.

Abstract: A gas diffuser plate in a cyclic deposition chamber is disclosed. The gas diffuser plate as fabricated comprises a substrate diffuser plate having a substrate emissivity and a coating formed on the substrate diffuser plate. The gas diffuser plate having the substrate diffuser plate coated with the coating has an emissivity higher than the substrate emissivity. The coating comprises a first layer formed on the substrate diffuser plate and comprising a first material configured to modulate the emissivity of the gas diffuser plate, and a second layer comprising a second corrosion-resistant material. The first material comprises titanium nitride oxide (TiNxOy). The emissivity of the gas diffuser plate is at least partially based on the ratio of nitrogen and oxygen in TiNxOy.

Abstract: The disclosed technology generally relates to forming a titanium nitride layer, and more particularly to forming by atomic layer deposition a titanium nitride layer on a seed layer. In one aspect, a semiconductor structure comprises a semiconductor substrate comprising a non-metallic surface. The semiconductor structure additionally comprises a seed layer comprising silicon (Si) and nitrogen (N) conformally coating the non-metallic surface and a TiN layer conformally coating the seed layer. Aspects are also directed to methods of forming the semiconductor structures.

Abstract: The disclosed technology generally relates to forming a thin film comprising titanium nitride (TiN), and more particularly to forming by a cyclical vapor deposition process the thin film comprising (TiN).